Your browser doesn't support javascript.
loading
Association between body mass index and subcortical brain volumes in bipolar disorders-ENIGMA study in 2735 individuals.
McWhinney, Sean R; Abé, Christoph; Alda, Martin; Benedetti, Francesco; Bøen, Erlend; Del Mar Bonnin, Caterina; Borgers, Tiana; Brosch, Katharina; Canales-Rodríguez, Erick J; Cannon, Dara M; Dannlowski, Udo; Díaz-Zuluaga, Ana M; Elvsåshagen, Torbjørn; Eyler, Lisa T; Fullerton, Janice M; Goikolea, Jose M; Goltermann, Janik; Grotegerd, Dominik; Haarman, Bartholomeus C M; Hahn, Tim; Howells, Fleur M; Ingvar, Martin; Kircher, Tilo T J; Krug, Axel; Kuplicki, Rayus T; Landén, Mikael; Lemke, Hannah; Liberg, Benny; Lopez-Jaramillo, Carlos; Malt, Ulrik F; Martyn, Fiona M; Mazza, Elena; McDonald, Colm; McPhilemy, Genevieve; Meier, Sandra; Meinert, Susanne; Meller, Tina; Melloni, Elisa M T; Mitchell, Philip B; Nabulsi, Leila; Nenadic, Igor; Opel, Nils; Ophoff, Roel A; Overs, Bronwyn J; Pfarr, Julia-Katharina; Pineda-Zapata, Julian A; Pomarol-Clotet, Edith; Raduà, Joaquim; Repple, Jonathan; Richter, Maike.
Afiliação
  • McWhinney SR; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Abé C; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Alda M; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Benedetti F; Vita-Salute San Raffaele University, Milan, Italy.
  • Bøen E; Division of Neuroscience, Psychiatry and Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Del Mar Bonnin C; Unit for Psychosomatics / CL Outpatient Clinic for Adults, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Borgers T; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona Bipolar Disorders and Depressive Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
  • Brosch K; Department of Psychiatry, University of Münster, Münster, Germany.
  • Canales-Rodríguez EJ; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Cannon DM; FIDMAG Germanes Hospitalàries Research Foundation, Barcelona, Spain.
  • Dannlowski U; Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Díaz-Zuluaga AM; Department of Psychiatry, University of Münster, Münster, Germany.
  • Elvsåshagen T; Research Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
  • Eyler LT; Norwegian Centre for Mental Disorders Research (NORMENT), Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Fullerton JM; Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
  • Goikolea JM; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Goltermann J; Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
  • Grotegerd D; Desert-Pacific MIRECC, VA San Diego Healthcare, San Diego, CA, USA.
  • Haarman BCM; Neuroscience Research Australia, Randwick, NSW, Australia.
  • Hahn T; School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.
  • Howells FM; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona Bipolar Disorders and Depressive Unit, Hospital Clinic, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
  • Ingvar M; Department of Psychiatry, University of Münster, Münster, Germany.
  • Kircher TTJ; Department of Psychiatry, University of Münster, Münster, Germany.
  • Krug A; Department of Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Kuplicki RT; Department of Psychiatry, University of Münster, Münster, Germany.
  • Landén M; Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • Lemke H; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
  • Liberg B; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Lopez-Jaramillo C; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Malt UF; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Martyn FM; Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
  • Mazza E; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • McDonald C; Department of Neuroscience and Physiology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.
  • McPhilemy G; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Meier S; Department of Psychiatry, University of Münster, Münster, Germany.
  • Meinert S; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Meller T; Research Group in Psychiatry GIPSI, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia.
  • Melloni EMT; Unit for Psychosomatics / CL Outpatient Clinic for Adults, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
  • Mitchell PB; Institute of Clinical Medicine, Department of Neurology, University of Oslo, Oslo, Norway.
  • Nabulsi L; Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Nenadic I; Vita-Salute San Raffaele University, Milan, Italy.
  • Opel N; Division of Neuroscience, Psychiatry and Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Ophoff RA; Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Overs BJ; Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.
  • Pfarr JK; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Pineda-Zapata JA; Department of Psychiatry, University of Münster, Münster, Germany.
  • Pomarol-Clotet E; Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.
  • Raduà J; Center for Mind, Brain and Behavior (CMBB), University of Marburg and Justus Liebig University Giessen, Marburg, Germany.
  • Repple J; Vita-Salute San Raffaele University, Milan, Italy.
  • Richter M; Division of Neuroscience, Psychiatry and Psychobiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Mol Psychiatry ; 26(11): 6806-6819, 2021 11.
Article em En | MEDLINE | ID: mdl-33863996
ABSTRACT
Individuals with bipolar disorders (BD) frequently suffer from obesity, which is often associated with neurostructural alterations. Yet, the effects of obesity on brain structure in BD are under-researched. We obtained MRI-derived brain subcortical volumes and body mass index (BMI) from 1134 BD and 1601 control individuals from 17 independent research sites within the ENIGMA-BD Working Group. We jointly modeled the effects of BD and BMI on subcortical volumes using mixed-effects modeling and tested for mediation of group differences by obesity using nonparametric bootstrapping. All models controlled for age, sex, hemisphere, total intracranial volume, and data collection site. Relative to controls, individuals with BD had significantly higher BMI, larger lateral ventricular volume, and smaller volumes of amygdala, hippocampus, pallidum, caudate, and thalamus. BMI was positively associated with ventricular and amygdala and negatively with pallidal volumes. When analyzed jointly, both BD and BMI remained associated with volumes of lateral ventricles  and amygdala. Adjusting for BMI decreased the BD vs control differences in ventricular volume. Specifically, 18.41% of the association between BD and ventricular volume was mediated by BMI (Z = 2.73, p = 0.006). BMI was associated with similar regional brain volumes as BD, including lateral ventricles, amygdala, and pallidum. Higher BMI may in part account for larger ventricles, one of the most replicated findings in BD. Comorbidity with obesity could explain why neurostructural alterations are more pronounced in some individuals with BD. Future prospective brain imaging studies should investigate whether obesity could be a modifiable risk factor for neuroprogression.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article